Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others


Parte II: COVID-19 y psoriasis 

Informes ibero-latinoamericanos del International Psoriasis Council (IPC)

Aprenda más sobre cómo COVID-19 está afectando a las personas con psoriasis. Vea el webinar de IPC para médicos en América Latina con pacientes con psoriasis. El programa de webinar incluye presentaciones sobre el impacto de COVID-19 en dermatólogos y pacientes en Portugal, Colombia y Paraguay y más.



André Vicente Esteves de Carvalho, MSc, MD, PhD
Hospital Moinhos de Vento 
Porto Alegre Brazil

Dr. André Vicente Esteves de Carvalho is responsible for the Psoriasis Ambulatory and a researcher at the Hospital Moinhos de Vento Complexo in Porto Alegre, Brazil. He is also a teacher at the Reumathology residency program at the same hospital, and a dermatology teacher at the Universidade do Vale do Rio dos Sinos Medical school. He is currently (2021-2022) the coordinator of the Psoriasis Department of the Brazilian Society of Dermatology (SBD). Dr. Carvalho is a dermatology specialist certified by the Brazilian Society of Dermatology. He completed specialization courses in Dermatologic Surgery and Mohs micrographic at the Dermatology School at Yale School of Medicine (2001) and has a master's degree in pathology from the Universidade Federal de Ciências da Saúde de Porto Alegre. In 2016 he received his PhD in pathology from the Universidade Federal de Ciências da Saúde de Porto Alegre. The title of his thesis is “Eficácia das Medicações Imunobiológicas e Inibidores de Pequenas Moléculas na Psoriase: Uma Revisão Sistemática e Metanálise de Ensaios Clínicos Randomizados” (“Efficacy of Immunobiologic and Small Molecule Inhibitors Drugs for Psoriasis: A Systematic Review and Meta-analysis of Randomized Clinical Trials”). He is the scientific reviewer for the Brazilian 2nd Edition of Dermatology, by Bolognia, Jorizzo, and Rappini, the Anais Brasileiros de Dermatologia, and several other peer-reviewed medical journals.

Last Updated: Jun 07, 2022

Matias Maskin, MD
CEMIC University, at Buenos Aires 
Buenos Aires Argentina

Dr. Matias Maskin is Assistant Professor at the Section of Dermatology, Department of Medicine, Centro de Educacion Medica e Investigaciones Clinicas (CEMIC) University, at Buenos Aires. He specializes in internal medicine and dermatology at the University of Buenos Aires and serves as Chief of Dermatology and Coordinator of the psoriasis section at the Instituto Universitario CEMIC. Dr. Maskin is a founding member of the Latin American Society of Psoriasis (SOLAPSO), is active in psoriasis education programs with SOLAPSO in Argentina, and is part of the SOLAPSO Biosimilars Consensus in Argentina. A member of IPC's Latin America working group, Dr. Maskin has authored national and international publications, has served as an investigator for many psoriasis clinical trials, and has participated in many national and international congress presentations pertaining to psoriasis.

Last Updated: Apr 14, 2022


Romina Contreras, MD
Hospital de Clínicas Department of Dermatology 
Asunción Paraguay
2019 Fellow

Dr. Contreras is a specialist in dermatology and venereology; she recently completed a Masters in Autoimmune Diseases. She holds clinic and teaches at the Hospital de Clínicas Department of Dermatology in Asunción, Paraguay where she is also in charge of the Teledermatology Unit. She has special interest in the integral management of psoriasis, combining clinical practice and research. She is the principal investigator for “VDR polymorphism and its relationship with psoriasis severity." For her 2019 Fellowship, Dr. Contreras was placed with Prof. Catherine Smith at the St. John’s Institute of Dermatology, in London, United Kingdom and attended the World Congress of Dermatology. During her time in London she observed Prof. Smith’s clinics on Psoriasis, Eczema, and Hidradenitis suppurativa (HS). She also attended the British Association of Dermatologists meeting in Liverpool and observed clinical cases at RSM (Royal Society of Medicine).

Last Updated: Aug 19, 2021

Francisco Kerdel, MD
Florida Academic Dermatology Center 
Miami, Florida United States

Dr. Francisco A Kerdel is the founder of Florida Academic Dermatology Centers. He is nationally and internationally renowned as one of the leaders in Medical Dermatology. Patients are referred to his practice from throughout the USA, Latin America and the Caribbean. Many of these patients are referred from other dermatologists in recognition of his clinical expertise and innovative approaches to treatment. He attended the St. Thomas Hospital Medical School, London University, United Kingdom. Dr. Kerdel completed his dermatology residency at Harvard Medical School, Boston, MA where he was chief resident during the year 1983-1984. He completed Fellowships at Guy's Hospital, London, England and New York University School of Medicine, New York, NY. He is the former Director of Dermatology Inpatient at The University of Miami Hospital, Miami, FL, and former Professor of Dermatology at the University of Miami. Dr. Kerdel is a clinical professor of dermatology at Florida International University.

Last Updated: Jun 26, 2020

Angela Londoño, MD
CES University 
Medellín Colombia

Dr. Londoño is the head of the dermatology program at CES University in Medellín, specializing in clinical and surgical dermatology. She graduated from the University Pontifica Bolivariana's dermatology program in 2004 and received her master's degree in epidemiology from CES University in 2009. She is the co-coordinator of the Colombian Group of Psoriasis and Psoriatic Arthritis (ColPsor), a group of dermatologists and rheumatologists interested in promoting psoriasis knowledge and improving the quality of life of patients who have these conditions. The group is supported by the Colombian Association of Dermatology and Dermatologic Surgery (Asocolderma). A founding member of the Latin American Society of Psoriasis (SOLAPSO), Dr. Londoño also served as editor of evidence-based guidelines for the management of psoriasis in Colombia in 2012 and 2015. She has participated in various psoriasis clinical trials and has authored various articles in national and international journals.  

Last Updated: Jun 26, 2020

Tiago Torres, MD, PhD
Abel Salazar Institute of Biomedical Sciences, 
Porto Portugal

Tiago Torres is Professor of Dermatology at the Abel Salazar Institute of Biomedical Sciences, University of Porto. He received his medical degree from the Faculty of Medicine, University of Porto, completed a residency program in Dermatology and Venereology at Centro Hospitalar do Porto and finished his PhD thesis in 2014 studying the role of psoriasis-associated systemic inflammation in atherosclerosis. Currently, he is the Head of the Psoriasis Unit and Clinical Trials Unit of the Department of Dermatology of Centro Hospitalar do Porto. Tiago Torres has been involved in the development of national guidelines for the treatment of psoriasis, has won the “Juvenal Esteves” Prize from the Portuguese Society of Dermatology and Venereology with research projects in psoriasis and psoriatic arthritis in 2011, 2013, 2017 and 2018 and is the present President of the Portuguese Group of Psoriasis. He serves as Associate Editor of Acta Médica Portuguesa, Journal of the Portuguese Society of Dermatology and Venereology and Drugs in Context and belongs to the editorial board of Drugs and the Foundation René Touraine’s Book “Therapeutics In Dermatology” and has been the editor of the Portuguese book “Psoriasis and Psoriatic Arthritis”. His main research topics in dermatology are immunodermatology, immunology and immunopharmacology of psoriasis and atopic dermatitis.

Last Updated: Jun 26, 2020

Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.

now available

COVID-19 Psoriasis Resource Center

Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve

explore now


on SARS-CoV-2 Vaccines and Psoriasis

Six key take-aways that physicians and other healthcare practitioners should consider when administering the SARS-CoV-2 vaccine to psoriasis patients.


We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.